Sun Pharma’s Halol Faces USFDA Inspection Setbacks After a 12-day review by the US drug regulator, Sun Pharma’s Halol facility is once again under regulatory scrutiny, bringing up concerns about compliance and the potential for future product approvals. Summary: Sun … Continue reading Sun Pharma’s Halol Faces USFDA Inspection Setbacks